A recent pre‑clinical investigation reports that a blend of five locally‑grown Nigerian vegetables can partially reverse hormone disturbances and safeguard uterine and ovarian tissues in female rats exposed to monosodium glutamate, hinting at possible applications for fibroid management.
Key findings
- The study used fifteen healthy albino female rats (190‑200 g) divided into three groups of five.
- Two groups received 800 mg kg⁻¹ of monosodium glutamate (MSG) daily for 30 days; one of these groups was subsequently treated with 100 mg kg⁻¹ of the vegetable blend for another 30 days.
- Hormone assays showed that luteinising hormone (LH), follicle‑stimulating hormone (FSH) and testosterone levels in the treated rats moved closer to control values, while estradiol improved modestly.
- Microscopic examination revealed preserved follicular development in ovaries and reduced cellular damage in uterine lining of the blend‑treated animals.
What vegetables made up the blend?
The Nigerian Indigenous Vegetable Blend (NIVB) consisted of equal parts of extracts from fluted pumpkin (Telfairia occidentalis), Lagos spinach (Celosia argentea), ebolo (Crassocephalum crepidioides), African spinach (Amaranthus hybridus) and African eggplant (Solanum macrocarpon). These species are widely consumed across Nigeria and are known locally by names such as soko, ebolo, tete and efo igbagba.
How was the experiment conducted?
Rats were allocated to a control group (no MSG), an MSG‑only group, and an MSG‑plus‑vegetable‑blend group. After the initial 30‑day MSG exposure, the third group received oral doses of the NIVB for a further month. At the study’s conclusion, blood samples were collected to measure FSH, LH, estradiol and testosterone, and reproductive organs were harvested for histological analysis.
What were the hormonal outcomes?
Exposure to MSG disrupted the normal hormonal profile, elevating LH and testosterone while suppressing FSH. Administration of the vegetable blend moderated these changes, bringing LH, FSH and testosterone nearer to baseline levels. Estradiol showed a slight, non‑significant rise, indicating a partial corrective effect.
What did microscopic analysis reveal?
Ovarian sections from blend‑treated rats displayed developing secondary and antral follicles, normal connective tissue, and luteinized cells essential for hormone synthesis. Uterine samples showed fewer signs of cellular necrosis and maintained structural integrity compared with the MSG‑only group, suggesting a protective role of the phytochemicals present in the vegetables.
What are the study’s limitations?
The research was performed on a small sample of fifteen rats and employed a laboratory model of MSG‑induced reproductive disturbance, which does not directly replicate human fibroid pathology. The investigators also used concentrated extracts rather than whole‑food consumption, leaving uncertainty about dietary relevance. Consequently, the authors caution that the blend is not yet a proven treatment for uterine fibroids in women.
What next steps are recommended?
Further investigations should clarify the active compounds, optimal dosing, safety profile and mechanisms of action. Ultimately, controlled human clinical trials will be required to determine whether the promising pre‑clinical results can be translated into effective, plant‑based interventions for women suffering from fibroids.